The main index of US stocks closed without common trend on Tuesday (21), with the Dow Jones retreating after quarterly results very encouraging, while the Nasdaq closed near the record high after a proposal for fusion in biotechnology.
The Dow Jones index fell 0.47% to 17,949 points. The S & amp; P 500 lost 0.15% to 2.097 points. The Nasdaq Composite rose 0.39% and closed at 5,014 points, 35 points less than its historical peak reached in March 2000.
Travelers, DuPont and IBM weighed on the Dow Jones. DuPont reported lower sales in all its business and said that a strong dollar will push its profit this year. IBM also mentioned currency effects to disclose drop in revenue on the night of Monday.
The season of corporate earnings the quarter ended in March is in full swing, with almost 73% of the S & amp components ;. P 500 that have reported results so far beating expectations for profit, but only 42.2%, exceeding revenue expectations
Investors struggle to assess how the strong dollar affect US multinationals including technology companies like Facebook, Google, Qualcomm, Microsoft to sell many of their products and services abroad and disseminate their results this week.
“There are several disparate items influencing the results. We are near a peak? Are we likely to restáveis is or there could be a fall? “said Mark Foster, chief investment officer of Kirr Marbach in Columbus, Indiana.
The dollar rose almost 9% since the beginning of year against a basket of major currencies, pressuring companies with large overseas operations.
Mylan Pharmaceutical rose 8.85%, to US $ 74.07 a share, after the Israeli competitor Teva make an offer unsolicited US $ 82 per share, in what could be the largest acquisition in the pharmaceutical industry this year. The Teva share rose 1.37%.
No comments:
Post a Comment